326 related articles for article (PubMed ID: 33585209)
1. Ubiquitin Carboxyl-Terminal Hydrolases and Human Malignancies: The Novel Prognostic and Therapeutic Implications for Head and Neck Cancer.
Rong C; Zhou R; Wan S; Su D; Wang SL; Hess J
Front Oncol; 2020; 10():592501. PubMed ID: 33585209
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin Carboxyl-Terminal Hydrolases (UCHs): Potential Mediators for Cancer and Neurodegeneration.
Sharma A; Liu H; Tobar-Tosse F; Chand Dakal T; Ludwig M; Holz FG; Loeffler KU; Wüllner U; Herwig-Carl MC
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486284
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin carboxyl-terminal hydrolases: involvement in cancer progression and clinical implications.
Fang Y; Shen X
Cancer Metastasis Rev; 2017 Dec; 36(4):669-682. PubMed ID: 29080080
[TBL] [Abstract][Full Text] [Related]
4. Phytochemicals as Potential Chemopreventive and Chemotherapeutic Agents for Emerging Human Papillomavirus-Driven Head and Neck Cancer: Current Evidence and Future Prospects.
Aggarwal N; Yadav J; Chhakara S; Janjua D; Tripathi T; Chaudhary A; Chhokar A; Thakur K; Singh T; Bharti AC
Front Pharmacol; 2021; 12():699044. PubMed ID: 34354591
[TBL] [Abstract][Full Text] [Related]
5. Deubiquitinating enzymes in oocyte maturation, fertilization and preimplantation embryo development.
Mtango NR; Latham KE; Sutovsky P
Adv Exp Med Biol; 2014; 759():89-110. PubMed ID: 25030761
[TBL] [Abstract][Full Text] [Related]
6. Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer: Comparison with cervical cancer.
Ekanayake Weeramange C; Shu D; Tang KD; Batra J; Ladwa R; Kenny L; Vasani S; Frazer IH; Dolcetti R; Ellis JJ; Sturm RA; Leo P; Punyadeera C
Cancer; 2022 May; 128(10):1937-1947. PubMed ID: 35176174
[TBL] [Abstract][Full Text] [Related]
7. A fluorescence assay for elucidating the substrate specificities of deubiquitinating enzymes.
Yin ST; Huang H; Zhang YH; Zhou ZR; Song AX; Hong FS; Hu HY
Biochem Biophys Res Commun; 2011 Dec; 416(1-2):76-9. PubMed ID: 22086173
[TBL] [Abstract][Full Text] [Related]
8. Potential oncogenic roles of mutant-p53-derived exosomes in the tumor-host interaction of head and neck cancers.
Azulay EE; Cooks T; Elkabets M
Cancer Immunol Immunother; 2020 Feb; 69(2):285-292. PubMed ID: 31897662
[TBL] [Abstract][Full Text] [Related]
9. The potential role of ubiquitin c-terminal hydrolases in oncogenesis.
Fang Y; Fu D; Shen XZ
Biochim Biophys Acta; 2010 Aug; 1806(1):1-6. PubMed ID: 20302916
[TBL] [Abstract][Full Text] [Related]
10. Friend or Foe: UCHL3 Mediated Carcinogenesis and Current Approaches in Small Molecule Inhibitors' Development.
Samy MA; Abd El Fatah NM; Yahia SE; Arafa RK
Curr Med Chem; 2021; 28(42):8782-8799. PubMed ID: 34238144
[TBL] [Abstract][Full Text] [Related]
11. Examining the incidence of human papillomavirus-associated head and neck cancers by race and ethnicity in the U.S., 1995-2005.
Cole L; Polfus L; Peters ES
PLoS One; 2012; 7(3):e32657. PubMed ID: 22448226
[TBL] [Abstract][Full Text] [Related]
12. Current research on head and neck cancer-associated long noncoding RNAs.
Song W; Sun Y; Lin J; Bi X
Oncotarget; 2018 Jan; 9(1):1403-1425. PubMed ID: 29416703
[TBL] [Abstract][Full Text] [Related]
13. Multiple ubiquitin C-terminal hydrolases from chick skeletal muscle.
Woo SK; Lee JI; Park IK; Yoo YJ; Cho CM; Kang MS; Ha DB; Tanaka K; Chung CH
J Biol Chem; 1995 Aug; 270(32):18766-73. PubMed ID: 7642526
[TBL] [Abstract][Full Text] [Related]
14. HPV-mediated regulation of SMAD4 modulates the DNA damage response in head and neck cancer.
Citro S; Miccolo C; Medda A; Ghiani L; Tagliabue M; Ansarin M; Chiocca S
J Exp Clin Cancer Res; 2022 Feb; 41(1):59. PubMed ID: 35144669
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus genome variants and head and neck cancers: a perspective.
Combes JD; Franceschi S
Infect Agent Cancer; 2018; 13():13. PubMed ID: 29643933
[TBL] [Abstract][Full Text] [Related]
16. A Current Update on Human Papillomavirus-Associated Head and Neck Cancers.
Tumban E
Viruses; 2019 Oct; 11(10):. PubMed ID: 31600915
[TBL] [Abstract][Full Text] [Related]
17. Expression of chemokine CXCL8/9/10/11/13 and its prognostic significance in head and neck cancer.
Zhao Z; Ma Y; Lv J; Maimaiti N; Zhang J; Aibibula M; Gong Z; Ling B
Medicine (Baltimore); 2022 Jul; 101(30):e29378. PubMed ID: 35905218
[TBL] [Abstract][Full Text] [Related]
18. Landscape assessment for gender neutral human papillomavirus vaccination recommendations including head and neck cancer burden data.
Morais E; El Mouaddin N; Schuurman S; De A
Vaccine; 2021 Sep; 39(39):5461-5473. PubMed ID: 34452775
[TBL] [Abstract][Full Text] [Related]
19. Promising Biomarkers in Head and Neck Cancer: The Most Clinically Important miRNAs.
Thomaidou AC; Batsaki P; Adamaki M; Goulielmaki M; Baxevanis CN; Zoumpourlis V; Fortis SP
Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897831
[TBL] [Abstract][Full Text] [Related]
20. Practices regarding human Papillomavirus counseling and vaccination in head and neck cancer: a Canadian physician questionnaire.
Anderson S; Isaac A; Jeffery CC; Robinson JL; Isaac DM; Korownyk C; Biron VL; Seikaly H
J Otolaryngol Head Neck Surg; 2017 Oct; 46(1):61. PubMed ID: 29073940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
